Product Name

  • Name

    Acemetacin

  • EINECS 258-403-4
  • CAS No. 53164-05-9
  • Article Data14
  • CAS DataBase
  • Density 1.36 g/cm3
  • Solubility
  • Melting Point 151.5 °C
  • Formula C21H18ClNO6
  • Boiling Point 565.5 °C at 760 mmHg
  • Molecular Weight 415.83
  • Flash Point 295.8 °C
  • Transport Information UN 2811
  • Appearance Light yellow solid
  • Safety 22-25-36/37/39-45
  • Risk Codes 26/27/28
  • Molecular Structure Molecular Structure of 53164-05-9 (Acemetacin)
  • Hazard Symbols VeryT+
  • Synonyms 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-aceticacid carboxymethyl ester;1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-aceticacid carboxymethyl ester;2-[2-[1-[(4-Chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl]acetyloxy]aceticacid;Acemet;Acemethacin;Acemix;Emflex;K 708;Rantudil;Rheumibis;Rheutrop;Solart;TV 1322;TVX 1322;
  • PSA 94.83000
  • LogP 3.47050

Synthetic route

acemetacin tert-butyl ester
75302-98-6

acemetacin tert-butyl ester

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
With hydrogenchloride; acetic anhydride In acetic acid at 80℃; for 5h; Large scale;99.45%
With trifluoroacetic acid In dichloromethane at 20℃; for 48h;80%
2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid tert-butyl ester
1601-20-3

2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid tert-butyl ester

acetic acid
64-19-7

acetic acid

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
With hydrogenchloride; aluminum (III) chloride at 60℃; for 5h; Reagent/catalyst; Temperature; Large scale;98.8%
<1-(4-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy>essigsaeurebenzylester
53164-04-8

<1-(4-Chlorbenzoyl)-5-methoxy-2-methylindol-3-acetoxy>essigsaeurebenzylester

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
With aluminum (III) chloride In dichloromethane; N,N-dimethyl-formamide at 80℃; for 24h; Temperature;97.8%
With palladium 10% on activated carbon; hydrogen In ethyl acetate at 20℃; under 760.051 Torr; for 20h;95%
With hydrogen; palladium on activated charcoal In ethyl acetate at 40℃; for 1h;93%
acemetacin tert-butyl ester
75302-98-6

acemetacin tert-butyl ester

A

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid
53-86-1

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid

B

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
With iodine; aluminium In acetonitrile at 20℃; for 6h; chemoselective reaction;A 30%
B 66%
4-methoxyphenylhydrazine hydrochloride
19501-58-7

4-methoxyphenylhydrazine hydrochloride

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 80 percent / acetic acid / 1.) 42 h, 28 deg C, 2.) 5 h, 50 deg C
2: 78 percent / various solvent(s) / 3 h / 190 - 195 °C
3: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
(5-Methoxy-2-methylindol-3-acetoxy)essigsaeurebenzylester
53164-08-2

(5-Methoxy-2-methylindol-3-acetoxy)essigsaeurebenzylester

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 78 percent / various solvent(s) / 3 h / 190 - 195 °C
2: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid
53-86-1

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) K2CO3 / 1.) DMF, 45 min, 50 deg C, 2.) 3 h, 50 deg C
2: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
levulinic acid
123-76-2

levulinic acid

phosphorus pentasulfide

phosphorus pentasulfide

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) K2CO3 / 1.) DMF, 70 min, 40 deg C, 2.) 4 h, 50 deg C
2: 80 percent / acetic acid / 1.) 42 h, 28 deg C, 2.) 5 h, 50 deg C
3: 78 percent / various solvent(s) / 3 h / 190 - 195 °C
4: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
Laevulinoyloxyessigsaeurebenzylester
53164-03-7

Laevulinoyloxyessigsaeurebenzylester

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 80 percent / acetic acid / 1.) 42 h, 28 deg C, 2.) 5 h, 50 deg C
2: 78 percent / various solvent(s) / 3 h / 190 - 195 °C
3: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
4-Methoxyphenylhydrazin-β-sulfonsaeure Natriumsalz

4-Methoxyphenylhydrazin-β-sulfonsaeure Natriumsalz

acemetacin
53164-05-9

acemetacin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 68 percent / conc. HCl / H2O / 2 h / 20 °C
2: 80 percent / acetic acid / 1.) 42 h, 28 deg C, 2.) 5 h, 50 deg C
3: 78 percent / various solvent(s) / 3 h / 190 - 195 °C
4: 93 percent / H2 / 5 percent Pd/C / ethyl acetate / 1 h / 40 °C
View Scheme
N-methyl-N-(2-nitrooxyethyl)ammonium nitrate
145459-16-1

N-methyl-N-(2-nitrooxyethyl)ammonium nitrate

acemetacin
53164-05-9

acemetacin

(N-methyl-N-(2-(nitrooxy)ethyl)carbamoyl)methyl 2-(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl)acetate
646511-41-3

(N-methyl-N-(2-(nitrooxy)ethyl)carbamoyl)methyl 2-(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl)acetate

Conditions
ConditionsYield
With 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; dmap; triethylamine In dichloromethane at 20℃;85%
2-nitroxyethylammonium nitrate
4665-58-1

2-nitroxyethylammonium nitrate

acemetacin
53164-05-9

acemetacin

(N-(2-(nitrooxy)ethyl)carbamoyl)methyl 2-(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl)acetate
646511-43-5

(N-(2-(nitrooxy)ethyl)carbamoyl)methyl 2-(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl)acetate

Conditions
ConditionsYield
With 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; 2-(Dimethylamino)pyridine60%
{(1R,2R)-cyclohexane-1,2-diamine}dichloridoplatinum(II)
38780-40-4, 52691-24-4, 61848-70-2, 61848-66-6, 61848-62-2

{(1R,2R)-cyclohexane-1,2-diamine}dichloridoplatinum(II)

acemetacin
53164-05-9

acemetacin

C27H31Cl2N3O6Pt

C27H31Cl2N3O6Pt

Conditions
ConditionsYield
With sodium carbonate; silver nitrate In N,N-dimethyl-formamide at 20℃; for 24h; Darkness;53%
methanol
67-56-1

methanol

acemetacin
53164-05-9

acemetacin

2-methoxy-2-oxoethyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate

2-methoxy-2-oxoethyl 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate

Conditions
ConditionsYield
With tert.-butylnitrite at 40℃; for 48h; Green chemistry;48%
acemetacin
53164-05-9

acemetacin

rubitecan
91421-42-0

rubitecan

acemetacin

acemetacin

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide; dmap In DMF (N,N-dimethyl-formamide) at 20℃; for 96h;32%
acemetacin
53164-05-9

acemetacin

A

2-(4-Chlorphenyl)-6-methoxy-4H-3.1-benzoxazinon-4

2-(4-Chlorphenyl)-6-methoxy-4H-3.1-benzoxazinon-4

B

N-(4-Chlor-benzoyl)-5-methoxy-anthranilsaeuremethylester

N-(4-Chlor-benzoyl)-5-methoxy-anthranilsaeuremethylester

C

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-essigsaeuremethylester

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-essigsaeuremethylester

D

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-acetoxy-essigsaeure

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-acetoxy-essigsaeure

Conditions
ConditionsYield
With oxygen; methylene blue In methanol for 10h; Irradiation; Further byproducts given;A 24%
B 21%
C 11%
D 21%
acemetacin
53164-05-9

acemetacin

A

2-Acetyl-N-(4-chlor-benzoyl)-4-methoxy-anilin

2-Acetyl-N-(4-chlor-benzoyl)-4-methoxy-anilin

B

N-(4-Chlor-benzoyl)-5-methoxy-anthranilsaeuremethylester

N-(4-Chlor-benzoyl)-5-methoxy-anthranilsaeuremethylester

C

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-essigsaeuremethylester

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-essigsaeuremethylester

D

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-acetoxy-essigsaeure

<2-(4-Chlor-benzoylamino)-5-methoxy>-benzoyl-2-acetoxy-essigsaeure

Conditions
ConditionsYield
With oxygen; methylene blue In methanol for 10h; Irradiation; Further byproducts given;A 10%
B 21%
C 11%
D 21%
acemetacin
53164-05-9

acemetacin

A

5-methoxy-2-methylindol-3-yl acetic acid carboxymethyl ester

5-methoxy-2-methylindol-3-yl acetic acid carboxymethyl ester

B

para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

Conditions
ConditionsYield
With sodium hydroxide at 30℃; Kinetics; Equilibrium constant; Further Variations:; Solvents; detergents; micelles; zwitterionic micelles;
With borate buffer at 30℃; pH=9.65; Kinetics; Equilibrium constant; Further Variations:; with/without L-α-phosphatidylcholine vesicles; detergents; micelles;
With perchloric acid In water at 25℃; Kinetics; Product distribution;
acemetacin
53164-05-9

acemetacin

A

5-Methoxy-2-methylindole-3-acetic acid
2882-15-7

5-Methoxy-2-methylindole-3-acetic acid

B

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid
53-86-1

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid

C

5-methoxy-2-methylindol-3-yl acetic acid carboxymethyl ester

5-methoxy-2-methylindol-3-yl acetic acid carboxymethyl ester

D

para-chlorobenzoic acid
74-11-3

para-chlorobenzoic acid

Conditions
ConditionsYield
In water at 30℃; Kinetics; Further Variations:; pH-values; Temperatures;
acemetacin
53164-05-9

acemetacin

4-chloro-N-hydroxybenzamide
1613-88-3

4-chloro-N-hydroxybenzamide

Conditions
ConditionsYield
Stage #1: acemetacin With sodium hydroxide; hydroxylamine hydrochloride
Stage #2: With hydrogenchloride; iron(III) chloride
Cu2(CH3COO)4(H2O)2

Cu2(CH3COO)4(H2O)2

acemetacin
53164-05-9

acemetacin

N,N-dimethyl-formamide
68-12-2, 33513-42-7

N,N-dimethyl-formamide

A

bis(N,N-dimethylformamide)bis-(O,O'-ACM)copper(II)

bis(N,N-dimethylformamide)bis-(O,O'-ACM)copper(II)

B

bis(N,N-dimethylformamide)tetrakis-μ-(O,O'-ACM)dicopper(II)

bis(N,N-dimethylformamide)tetrakis-μ-(O,O'-ACM)dicopper(II)

Conditions
ConditionsYield
at 20 - 35℃;
1H-imidazole
288-32-4

1H-imidazole

Cu2(CH3COO)4(H2O)2

Cu2(CH3COO)4(H2O)2

acemetacin
53164-05-9

acemetacin

bis(O,O'-acemetacin)bis(imidazole)copper(II)

bis(O,O'-acemetacin)bis(imidazole)copper(II)

Conditions
ConditionsYield
In methanol; water for 0.416667h;
zinc diacetate
557-34-6

zinc diacetate

water
7732-18-5

water

acemetacin
53164-05-9

acemetacin

bis(O,O'-acemetacin)diaquzinc(II)

bis(O,O'-acemetacin)diaquzinc(II)

Conditions
ConditionsYield
In ethanol at 60℃;
Cu2(CH3COO)4(H2O)2

Cu2(CH3COO)4(H2O)2

water
7732-18-5

water

acemetacin
53164-05-9

acemetacin

bis(O,O'-acemetacin)diaquacopper(II)

bis(O,O'-acemetacin)diaquacopper(II)

Conditions
ConditionsYield
In ethanol at 20 - 40℃;
[Co(NH3)5(OSO2CF3)](CF3SO3)2

[Co(NH3)5(OSO2CF3)](CF3SO3)2

acemetacin
53164-05-9

acemetacin

pentaammine(acemetacin)cobalt(III) bis(trifluoromethanesuIfonate)

pentaammine(acemetacin)cobalt(III) bis(trifluoromethanesuIfonate)

Conditions
ConditionsYield
With triethylamine In dimethyl sulfoxide at 50 - 80℃; for 5h;
1,2,3,4-tetra-O-trimethylsilyl-β-D-glucopyranose
98461-21-3

1,2,3,4-tetra-O-trimethylsilyl-β-D-glucopyranose

acemetacin
53164-05-9

acemetacin

C39H60ClNO11Si4

C39H60ClNO11Si4

Conditions
ConditionsYield
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃; for 5h;
acemetacin
53164-05-9

acemetacin

acemetacin (S)-duloxetine salt
1309349-71-0

acemetacin (S)-duloxetine salt

Conditions
ConditionsYield
Stage #1: Duloxetine; acemetacin In tetrahydrofuran; methanol
Stage #2: In di-isopropyl ether at 12℃; for 12h;
In tetrahydrofuran; methanol Product distribution / selectivity;

acemetacin Chemical Properties

Systematic (IUPAC) name :2-[2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetyl]oxyacetic acid
Formula: C21H18ClNO6 
Mol. mass :415.82372 g/mol

acemetacin History

Acemetacin  is manufactured by Merck under the tradename Emflex, and is available in the UK as a prescription-only drug.

acemetacin Uses

    Acemetacin is a non-steroidal anti-inflammatory drug, used for the treatment of osteoarthritis, rheumatoid arthritis, lower back pain, and relieving post-operative pain.
    Acemetacin, a glycolic acid ester of indometacin, acts as a prodrug; in the body, it is metabolized to indometacin, which then acts as an inhibitor of cyclooxygenase, producing the anti-inflammatory effects.

acemetacin Consensus Reports

    An advantage of acemetacin is that it reduces gastric damage when compared to indometacin.
Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View